Search News

October | 27/10/2020

IMPORTANT - SSPs issued for fluoxetine capsules 30mg and Salazopyrin EN-Tabs 500mg have come into effect from Tuesday 20 October 2020 – England and Wales

October | 24/10/2020

Superintendent update on the MSO Quarterly report (April- June 2020)

October | 22/10/2020

Highlighting OTC medicines which can potentially be misused.

October | 21/10/2020

The PPE Portal has changed from being an ‘emergency top-up’ system to being the primary source of COVID-19 PPE requirements for Primary Care providers including community pharmacists.

October | 19/10/2020

The Department of Health and Social Care (DHSE) alongside the Medicines and Healthcare products Regulatory Agency (MHRA) recently published the outcome of a consultation on changes to the Human Medicines Regulations to support the rollout of COVID-19 vaccines.

October | 16/10/2020

The National Pharmacy Association (NPA) is calling on Public Health England (PHE) to iron out discrepancies in its guidance on Covid-19 antibody testing, which currently bars pharmacists from conducting the tests.

October | 14/10/2020

DHSC and PHE address concerns over the supply of flu vaccine for the NHS flu service 2020/21 and why some patients may be asked to wait

October | 14/10/2020

From 1 October 2020, businesses including community pharmacies are to stop supplying these products to customers, unless exemptions apply

October | 14/10/2020

A Class 2 medicines recall drug alert issued on Epilim gastro-resistant tablets 500mg

October | 14/10/2020

From 14 October 2020, a three-tiered system of local COVID alert levels will apply. On 13 October 2020, guidance on shielding and supporting clinically extremely vulnerable groups has been updated.